Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program Experience.
Publication
, Journal Article
Johansen, KL; Acharya, A; Cizman, B; Cobitz, AR; Correa-Rotter, R; Dasgupta, I; Kher, V; Lopes, RD; Matsumoto, L; Meadowcroft, AM; Okabe, M ...
Published in: Kidney360
April 28, 2022
The coronavirus disease 2019 pandemic has had an unprecedented effect on health and health care and posed challenges to the conduct of clinical trials.Targeted mitigating strategies, on the basis of early and continued data collection from site surveys, limited disruption to the ASCEND trials.Flexibly allowing hemoglobin assessment at local laboratories to inform randomized treatment dosing was key to limiting the discontinuation of treatment.
Duke Scholars
Published In
Kidney360
DOI
EISSN
2641-7650
Publication Date
April 28, 2022
Volume
3
Issue
4
Start / End Page
728 / 733
Location
United States
Related Subject Headings
- Pandemics
- Humans
- Data Collection
- Clinical Trials as Topic
- COVID-19
- 4202 Epidemiology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Johansen, K. L., Acharya, A., Cizman, B., Cobitz, A. R., Correa-Rotter, R., Dasgupta, I., … Singh, A. K. (2022). Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program Experience. Kidney360, 3(4), 728–733. https://doi.org/10.34067/KID.0006212021
Johansen, Kirsten L., Anjali Acharya, Borut Cizman, Alexander R. Cobitz, Ricardo Correa-Rotter, Indranil Dasgupta, Vijay Kher, et al. “Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program Experience.” Kidney360 3, no. 4 (April 28, 2022): 728–33. https://doi.org/10.34067/KID.0006212021.
Johansen KL, Acharya A, Cizman B, Cobitz AR, Correa-Rotter R, Dasgupta I, et al. Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program Experience. Kidney360. 2022 Apr 28;3(4):728–33.
Johansen, Kirsten L., et al. “Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program Experience.” Kidney360, vol. 3, no. 4, Apr. 2022, pp. 728–33. Pubmed, doi:10.34067/KID.0006212021.
Johansen KL, Acharya A, Cizman B, Cobitz AR, Correa-Rotter R, Dasgupta I, Kher V, Lopes RD, Matsumoto L, Meadowcroft AM, Merege Vieira Neto O, Okabe M, Rayner B, Silva A, Thomas H, Singh AK. Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program Experience. Kidney360. 2022 Apr 28;3(4):728–733.
Published In
Kidney360
DOI
EISSN
2641-7650
Publication Date
April 28, 2022
Volume
3
Issue
4
Start / End Page
728 / 733
Location
United States
Related Subject Headings
- Pandemics
- Humans
- Data Collection
- Clinical Trials as Topic
- COVID-19
- 4202 Epidemiology
- 3202 Clinical sciences